SCHEDULE 5
BLOCK LISTING SIX MONTHLY RETURN
To: Listing Applications
UK Listing Authority
Financial Services Authority
25, The North Colonnade
Canary Wharf
London, E14 5HS
Please ensure the entries on this return are type
1. Name of company THE LAW DEBENTURE CORPORATION p.l.c.
2. Name of scheme EXECUTIVE SHARE OPTION SCHEME
3. Period of return: From 8 JUNE 2006 TO 7 DECEMBER 2006
4. Number and class of share(s) (amount 244,290
of stock/debt security) not issued
under scheme
5. Number of shares issued/allotted NIL
under scheme during period:
6. Balance under scheme not yet issued/ 244,290
allotted at end of period
7. Number and class of share(s) (amount 22,681,103 ORDINARY 5P SHARES LISTED
of stock/debt securities) originally AT VARIOUS TIMES SINCE THE
listed and the date of admission; CORPORATION'S INCORPORATION AND
ADMISSION IN 1889
Please confirm total number of shares in issue at the end of the period in
order for us to update our records
117,720,013
Contact for queries: SHARON TYSON Address: FIFTH FLOOR
100 WOOD STREET
LONDON EC2V 7EX
Name: Telephone: 020 7696 5233
Person making return Name SHARON TYSON
Position DEPUTY COMPANY SECRETARY Signature:………………………………………………
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.